PL369754A1 - Liofilizowany preparat zawierający immunocytokiny - Google Patents

Liofilizowany preparat zawierający immunocytokiny

Info

Publication number
PL369754A1
PL369754A1 PL03369754A PL36975403A PL369754A1 PL 369754 A1 PL369754 A1 PL 369754A1 PL 03369754 A PL03369754 A PL 03369754A PL 36975403 A PL36975403 A PL 36975403A PL 369754 A1 PL369754 A1 PL 369754A1
Authority
PL
Poland
Prior art keywords
immunocytokine
lyophilized preparation
containing lyophilized
preparation
reconstitution
Prior art date
Application number
PL03369754A
Other languages
English (en)
Inventor
Hans-Peter Zobel
Sven Oliver Arndt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL369754A1 publication Critical patent/PL369754A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL03369754A 2002-02-06 2003-01-14 Liofilizowany preparat zawierający immunocytokiny PL369754A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10204792A DE10204792A1 (de) 2002-02-06 2002-02-06 Lyophilisierte Zubereitung enthaltend Immuncytokine

Publications (1)

Publication Number Publication Date
PL369754A1 true PL369754A1 (pl) 2005-05-02

Family

ID=27588393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03369754A PL369754A1 (pl) 2002-02-06 2003-01-14 Liofilizowany preparat zawierający immunocytokiny

Country Status (17)

Country Link
US (1) US20050220758A1 (pl)
EP (1) EP1471942A1 (pl)
JP (1) JP4422485B2 (pl)
KR (1) KR20040091015A (pl)
CN (1) CN1627958A (pl)
AR (1) AR038355A1 (pl)
AU (1) AU2003244470B2 (pl)
BR (1) BR0307448A (pl)
CA (1) CA2475211A1 (pl)
DE (1) DE10204792A1 (pl)
MX (1) MXPA04007562A (pl)
PE (1) PE20030898A1 (pl)
PL (1) PL369754A1 (pl)
RU (1) RU2316348C2 (pl)
TW (1) TW200303756A (pl)
WO (1) WO2003066102A1 (pl)
ZA (1) ZA200407028B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9770517B2 (en) 2002-03-01 2017-09-26 Immunomedics, Inc. Anti-Trop-2 antibody-drug conjugates and uses thereof
JP2006045162A (ja) * 2004-08-06 2006-02-16 Takeda Chem Ind Ltd 注射用ペプチド含有組成物
AU2005277357B2 (en) * 2004-08-17 2011-08-04 Regeneron Pharmaceuticals, Inc. IL-1 antagonist formulations
US8129533B2 (en) * 2005-09-28 2012-03-06 Dalichi Sankyo Company, Limited Method for production of quinolone-containing lyophilized preparation
CA2634547C (en) 2005-12-20 2016-10-11 Bristol-Myers Squibb Company Stable ctla4 formulation for subcutaneous administration
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
DE102007050165B4 (de) * 2007-10-19 2010-06-17 Stiftung Tierärztliche Hochschule Hannover Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung
CA2753641C (en) * 2009-02-25 2014-09-16 Supratek Pharma, Inc. Bendamustine cyclopolysaccharide compositions
TWI527590B (zh) * 2011-06-17 2016-04-01 艾瑞斯貿易公司 Ｆｇｆ－１８之凍乾調配物
US9382329B2 (en) 2012-08-14 2016-07-05 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to Trop-2 expressing cells
CA2920192A1 (en) * 2013-09-27 2015-04-02 Immunomedics, Inc. Anti-trop-2 antibody-drug conjugates and uses thereof
CA2947396C (en) 2014-04-28 2021-10-19 Eisai R&D Management Co., Ltd. Lyophilized formulation of hgf
RU2747977C2 (ru) 2016-03-17 2021-05-18 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ получения активного фактора роста гепатоцитов (hgf)
CN116327966A (zh) * 2021-12-24 2023-06-27 广州达安基因股份有限公司 冻干保护剂、il-6冻干粉剂及其制备方法
CN114224853B (zh) * 2022-01-04 2022-09-23 山东新时代药业有限公司 聚乙二醇化重组人粒细胞刺激因子注射用冻干制剂
CN114515334B (zh) * 2022-02-22 2024-02-20 史辛艺 一种脂肪间充质干细胞因子冻干粉及其制备方法
JPWO2025013783A1 (pl) * 2023-07-07 2025-01-16

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150067A3 (en) * 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
JPS61197527A (ja) * 1985-02-25 1986-09-01 Takeda Chem Ind Ltd インタ−ロイキン−２組成物
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
EP0374257B1 (en) * 1988-05-06 1994-08-31 Toray Industries, Inc. STABLE INTERFERON $g(b) COMPOSITION
US5104651A (en) * 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
JP3822383B2 (ja) * 1993-12-17 2006-09-20 持田製薬株式会社 可溶性トロンボモジュリン含有組成物
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
TW497972B (en) * 1995-06-08 2002-08-11 Kirin Brewery Stable thrombopoietin (TPO)-containing lyophilized compositions
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
RU2129878C1 (ru) * 1996-04-24 1999-05-10 Зинченко Елена Вениаминовна Иммуномодулирующий препарат с противовирусной активностью "неоферон"
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern

Also Published As

Publication number Publication date
EP1471942A1 (de) 2004-11-03
RU2004126942A (ru) 2005-06-10
PE20030898A1 (es) 2003-10-25
ZA200407028B (en) 2006-02-22
KR20040091015A (ko) 2004-10-27
WO2003066102A1 (de) 2003-08-14
MXPA04007562A (es) 2004-11-10
JP4422485B2 (ja) 2010-02-24
CN1627958A (zh) 2005-06-15
AU2003244470A1 (en) 2003-09-02
AR038355A1 (es) 2005-01-12
US20050220758A1 (en) 2005-10-06
RU2316348C2 (ru) 2008-02-10
JP2005516998A (ja) 2005-06-09
AU2003244470B2 (en) 2008-03-13
DE10204792A1 (de) 2003-08-14
TW200303756A (en) 2003-09-16
CA2475211A1 (en) 2003-08-14
BR0307448A (pt) 2004-12-28

Similar Documents

Publication Publication Date Title
BR0307448A (pt) Preparação liofilizada compreendendo imunocitocinas
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
SG98393A1 (en) Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
IL229304A (en) Compounds 1 ', 3' - Imaging Converts - 4 - Phenyl - 3, 4, 5, 6 - Tetrahydro - 2h, 1'h, [1, 4 '] Bipyridinyl - 2' - lozenges, pharmaceutical preparations containing them and their use
WO2004084950A3 (en) Cell targeting methods and compositions
WO2003011226A3 (en) Products and drug delivery vehicles
ZA200407794B (en) Novel biomaterials, their preparation and use.
EP2275125A3 (en) Protein-based streptococcus pneumoniae vaccines
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
MXPA03008310A (es) Interferon beta modificado con inmunogenicidad reducida.
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
ATE509951T1 (de) Humanes interferon-beta-mutein
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
SI1831240T1 (sl) 18-metil-19-nor-17-pregn-4-en-21,17-karbolaktoni in farmacevtski sestavki, ki jih vsebujejo
MXPA05010613A (es) Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo.
HUP0002644A2 (hu) Aldóz reduktáz inhibítort és ACE inhibitort tartalmazó gyógyászati készítmények
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
TW200735875A (en) Pharmaceutical compositions
MXPA03007838A (es) Interferon alfa modificado con inmunogenicidad reducida.
EP1682565A4 (en) IAP NUCLEOBASE OLIGOMERS AND OLIGOMERE COMPLEXES AND APPLICATIONS THEREOF
AR061352A1 (es) El uso de timosina alfa 1 para preparar un medicamento destinado al tratamiento del melanoma maligno de estadio iv
FR12C0064I1 (pl)
AU2001230195A1 (en) Pharmaceutical compositions comprising terbinafine

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)